Cytosorbents Corporation (CTSO) vs Passage Bio, Inc. (PASG)
A side-by-side comparison of Cytosorbents Corporation and Passage Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTSO
Cytosorbents Corporation
$4.07HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
PASG
Passage Bio, Inc.
$4.12HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — CTSO vs PASG
growth of $100 · dividends reinvested · last 7yCTSO -96.9% (-39.2%/yr)PASG -99.1% (-48.8%/yr)CTSO compounded faster over this window
CTSO PASG
CTSO vs PASG: by the numbers
- •PASG is the larger company ($13M vs $13M market cap).
- •Both run net losses; PASG's is the smaller (0.00% vs -48.94% net margin).
Metrics side by side
Valuation
| Metric | CTSO | PASG |
|---|---|---|
| P/S ratio | 0.34 | N/A |
| P/B ratio | N/A | 2.97 |
Profitability
| Metric | CTSO | PASG |
|---|---|---|
| Gross margin | 71.61% | 0.00% |
| Operating margin | -33.37% | 0.00% |
| Net margin | -48.94% | 0.00% |
| ROE | N/A | -810.41% |
| ROIC | -43.31% | -889.92% |
Growth (annualized)
| Metric | CTSO | PASG |
|---|---|---|
| Revenue CAGR (5Y) | -3.17% | N/A |
| Total return CAGR (5Y) | -52.26% | -53.23% |
Frequently asked
- How have CTSO and PASG total returns compared?
- Over the past 5 years, CTSO delivered -52.26% and PASG delivered -53.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.